Table 1.
CNS species a | Geral (%) | CR b | NR b | ||
---|---|---|---|---|---|
Total | Outpatient | NI c | |||
S. epidermidis | 70 ( 34) | 17 | 2 | 15 | 53 |
S. warneri | 35 ( 17) | 9 | 3 | 6 | 26 |
S. haemolyticus | 33 ( 16) | 15 | 11 | 4 | 18 |
S. simulans | 21 ( 10) | 5 | 2 | 3 | 16 |
S. sciuri | 15 ( 7) | 4 | 3 | 1 | 11 |
S. saprophyticus | 5 ( 3) | 0 | 0 | 0 | 5 |
S. hominis | 4 ( 2) | 0 | 0 | 0 | 4 |
S. capitis | 4 ( 2) | 3 | 0 | 3 | 1 |
S. xylosus | 3 ( 2) | 1 | 1 | 0 | 2 |
S. auricularis | 1 ( 0) | 0 | 0 | 0 | 1 |
NDd | 13 ( 6) | 2 | 1 | 1 | 11 |
Total isolates | 204 (100) | 56 | 23 | 33 | 148 |
CNS species were identified by VITEK System Gram positive identification test (GPI) card;
Clinically relevant (CR) and non-relevant (NR) CNS isolates were classified on the basis of the criteria described in Materials and Methods;
Nosocomial infection (NI);
ND CNS which species were not identified.